Related Experiment Videos
HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in
Wieslawa H Dragowska1, Corinna Warburton, Donald T T Yapp
1Department of Advanced Therapeutics, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 4E6. vdragows@bccrc.ca.
Molecular Cancer Research : MCR
|November 25, 2004
Summary
HER-2/neu overexpression in breast cancer xenografts increases tumor viability and promotes a larger population of viable hypoxic cells. This occurs independently of significant changes in tumor vascularization, suggesting a complex microenvironment response.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- HER-2/neu overexpression is a hallmark of aggressive breast cancers.
- The tumor microenvironment significantly influences cancer progression and treatment response.
- Understanding the interplay between HER-2/neu and the microenvironment is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the impact of HER-2/neu overexpression on tumor viability and the tumor microenvironment.
- To assess the relationship between HER-2/neu, hypoxia, and vascularization in an aggressive breast cancer model.
Main Methods:
- Utilized a xenograft model of aggressive breast cancer (MDA-MB-435/LCC6 cells transfected with human c-erbB2).
- Assessed tumor viability using H&E staining, trypan blue exclusion, and clonogenic assays.
- Quantified hypoxia using EF5 staining and flow cytometry.
- Analyzed protein levels of p-NF-κB and HIF-1α.
- Evaluated tumor vasculature via CD31 staining and Hoechst 33342 perfusion.
Main Results:
- HER-2/neu overexpressing tumors (LCC6(HER-2)) exhibited significantly increased viability compared to controls (LCC6(Vector)).
- A greater fraction of hypoxic cells was observed in LCC6(HER-2) tumors (16.41%) versus LCC6(Vector) tumors (5.96%).
- Elevated phosphorylated nuclear factor-kappaB p65 and a trend for increased hypoxia-inducible factor-1alpha were found in LCC6(HER-2) tumors.
- Despite increased vascular endothelial growth factor, no significant differences in tumor vasculature were detected between groups.
Conclusions:
- HER-2/neu overexpression is associated with enhanced tumor cell viability and a substantial increase in viable hypoxic tumor cells.
- The observed hypoxia is not a consequence of altered tumor vascularization in this model.
- These findings highlight a complex tumor microenvironment adaptation in HER-2/neu-driven breast cancer.